duce the chemotaxis of various cell types, such as monoc y t e~,~ eosinophils: basophils: mast cells: and T and B lymphocytes,'** and are thought to play major roles in inflammati~n.~ Chemokines mediate their effects through interaction with receptors of the seven transmembrane spanning G-protein-linked receptor superfamily.lo3" G proteins are part of a large superfamily of proteins that are regulated by guanine nucleotides. The heterotrimeric G proteins are composed of three subunits, ie, a, @, and y . Each G protein is distinguished by its a subunit. Approximately 20 Ga proteins are presently described.I2 These have been historically classified into G stimulatory (Gs), G inhibitory (Gi), Go, and Gq. G, activates adenylyl cyclase (AC), resulting in the production of cyclic AMP, whereas Gi inhibits the activity of AC.13 Go activity is linked to the activation of ion channels such as Ca2', C1-, or K+.I4 Whereas G,, Gi, and Go are sensitive to bacterial toxins, Gq and G, are n~t . '~. '~ Using various methods to delineate the interaction between receptors and G proteins, it has been observed that receptors for most hormones, neurotransmitters, or cytokines are selective in their coupling to G proteins. Only few receptors, such as the a 2 adrenoreceptor, show promiscuous coupling to various subtypes of G proteins in various tissues. " We have recently reported that the CC chemokines macrophage inflammatory protein-la (MIP-la), regulated on activation normal T cell expressed and secreted (RANTES), and monocyte chemoattractant peptide-1 (MCP-1) but not ME'-lp induce the chemotaxis of the antitumor effectors interleukin-2-activated natural killer (IANK) cells. This activity is linked to the heterotrimeric guanine-nucleotide binding (G) proteins, suggesting a role for G proteins in transducing the chemotactic signals of CC chemokines.'* Similar results were observed when MCP-1 was used to attract natural killer (NK) ~e l 1 s . l~ Our present study examines the nature of the G proteins interacting with the various CC chemokines acting on the antitumor effectors, IANK cells.
MATERIALS AND METHODS
Culture medium (CM) consisted of RPMI-1640 supplemented with 10% human AB serum (NABI, Miami,
Culture medium.
G, anti-Go, or anti-Gz inhibited GTP binding and GTPase activity in the presence of MIP-la, MCP-1, or RANTES. (2) Anti-GI inhibited GTP binding and GTPase activity in the presence of MCP-1 or RANTES but not in the presence of MIP-la. The inhibitory effect of anti-G protein antibodies was reversed upon incubating these antibodies with their respective synthetic peptides before addition to IANK cell membranes. These results suggest that MCP-1 and RANTES receptors are promiscuously coupled to multiple G proteins in IANK cell membranes and that this coupling is different from MIP-la receptors, which seem to be coupled to G., Go, and G, but not to GI. 0 1996 by The American Society of Hematology. E), 10 U/mL penicillin, 100 pg/mL streptomycin, 1 mmom Lglutamine, 1% nonessential amino acids (all from GIBCO Laboratories, Burlington, Ontario, Canada), and 5 X m o m 2-mercaptoethanol (Sigma Chemicals, St Louis, MO).
Leupeptin, aprotinin, pepstatin A, phenylmethyl sulfonyl fluoride (PMSF), thymidine, GTP, DlT, EDTA, K+-glutamate, nitrilotriacetic acid, PIPES, and streptolysin 0 (SLO) were purchased from Sigma Chemicals. (-p3%) GTP (specific activity, 1,202 Ci/ "01) and (-p3'P) GTP (specific activity, 30 Cilmmol) were purchased from NEN DUPONT (Mississauga, Ontario, Canada). The reaction was terminated by adding 900 pL of cold buffer. After centrifugation at 12,OOOg in the cold and two rounds of washing, the pellet was dissolved in a scintillation cocktail and counted in a scintillation counter. All assays were performed in triplicate. GTPase assay. GTPase assay was performed by measuring the release of 32P from (Y-'~P) GTP, as d e~c r i b e d .~~,~' The reaction consisted of 50 pg membranes prepared from IANK cells incubated for 3 minutes at 37°C with CM or CC chemokines. The cells were washed and incubated in a total volume of 100 pL of buffer containing 25 mmoVL Tris-HCI, pH 8.0, 1 mmoVL EGTA, 1 mmoVL MgCI2, 138 mmol/L KCI, 0.1 pg/mL BSA, 0.5 mmol/L App (NH)p, 1 mmoVL DTT, 0.25 mmol/L ATP, 5 mmoVL phosphate creatine, 50 U/mL creatine phosphokinase, and (y-"P) GTP for 15 minutes at 37°C. The reaction was terminated by adding IO-fold of a second buffer containing 20 mmoVL K2HP0, pH 8.0, 5% charcoal, 0.5% BSA, and 0.1% dextran and was incubated on ice for 1 hour. The mixture was centrifuged at 16,OOOg for 2 minutes, and 200 pL of the supernatant was added to scintillation fluid and counted in a beta counter to determine (3ZP)-labeled inorganic phosphate. All assays were performed in triplicate.
Both GTP binding and GTPase assays were performed in the anti-G protein antibodies for 2 hours at 4°C. They were washed and then incubated with CC chemokines for 3 minutes at 37°C. After another round o f washing. the membranes were incubated with either ( y -" S ) GTP for GTP binding or with (y-"P) GTP for GTPase assay.
as described above.
In other experiments, the anti-G protein antibodies were incubated with the synthetic peptides used for immunization to generate the antibodies for 2 hours at 4°C before addition to I A N K cell membranes.
Chemotaxis assay was performed as previously described.'x ''I Nuclepore blind well chemotaxis chambers were incubated with buffer (Cont.), NRS, rabbit IgG, or 1:lOO dilution of affinity-purified anti-Gi, anti-G., anti-G., or anti-G. antibodies for 2 hours at 4°C. The membranes were washed in cold buffer at 4°C and were incubated for 3 minutes a t 37°C with either buffer (basal binding) or with 10 pg/mL of MIP-la, 100 pg/mL of MCP-1, or 10 pg/mL of RANTES. They were washed again and incubated with ( y " S ) GTP for 15 minutes at 37°C. Anti-Go, anti-G,, and anti-G, inhibited MIPla-, MCP-1-, o r RANTES-induced GTP binding ( P < .OW, whereas anti-G, inhibited MCP-1-or RANTES-induced ( P < .05) but not MIPla-induced GTP binding, as compared with that for the controls. (Bl IANK cell membranes were either incubated with a mixture of NRS or rabbit IgG, plus synthetic peptides or a mixture of anti-G protein antibodies plus corresponding synthetic peptides. NRS, rabbit IgG, or anti-G protein-to-synthetic peptide (1:lOO dilution t o 200 ng/mL) were incubated for 2 hours at 4°C before addition t o the membranes. Anti-Go was incubated with a . synthetic peptide (Cys-NLKEDGC SAAKDVKI, anti-(;, with ai synthetic peptide (LKDCGLF), anti-G, with a . synthetic peptide (RMHLRQYELL), anti-G, with a, synthetic peptide (QNNLKYIGLC), and NRS or rabbit IgG with ai, a . , a,, and a, synthetic peptides. The membranes were washed in cold buffer at 4°C and were incubated for 3 minutes at 37°C with either buffer (basal binding) or with 10 pg/mL MIP-la, 100 pg/mL MCP-1, or 10 rescaling of their membranes hefore examining their ability to migrate in the microchemotaxis chamhers.
Significant values were determined by using the two-tailed Student's t-test. 
RESULTS
The percentage of positive cells in IANK cell preparation was as follows: CD3, 5% ? 2%: CD4, 3% t I%: CD8. 46% ? 6%: CDS6. 83% t 2 1 %; B I. 2% ? I %: and M02.
< I %. IANK cells are devoid of CD3 expression, suggesting that the presence of CD8 is mainly confined to the CDS6-cells. In addition. most, if not all. IANK cells show the large granular lymphocyte (LGL) morphology (Fig I a) . indicating that they are NK cells.
We have recently reported an efficient procedure for the permeabilization of IANK cells and then introduction of anti-G protein antibodies inside these permeabilized cells." Permeabilized cells show typical LGL morphology (Fig 1 b) . suggesting that permeabilization did not affect their morphology. Furthermore. we have successfully introduced affinity-purified anti-G protein ( 1 : 100 dilution) inside these permeabilized cells (Fig 2) . The background fluorescence is brighter in the experimental treatments (Fig 2d through h) as compared with the controls (Fig 2a through c) . This is due to the retention of the second antibody in the former samples. FITC-conjugated F(ab')? binds tightly to a n t i 4 protein antibodies retained by permeabilized cells. which reflects on the background fluorescence noted in Fig 2d  through h. This finding confirmed our earlier findings showing that anti-G protein antibodies specifically bind to G pro- .,s . , z Fig 5. Effect of anti-G protein antibodies o n CC chemokine-induced GTP hydrolysis. This is similar t o Fig 4 except that GTPase activity rather than GTP binding was measured in this assay. Hence, (y-"P) GTP was used instead of ( y % ) GTP. In (A), anti-G., anti-G, and anti-G, inhibited MIP-la-, MCP-1-, or RANTES-induced GTPase activity ( P < .05) in IANK cell membranes, as compared with that for the controls. On the other hand, anti-G, inhibited RANTES and MCP-1-induced ( P < .05) but not MIP-la-induced GTPase activity. In (BI.
anti-G protein antibodies were incubated with synthetic G proteins before assaying for GTP hydrolysis.
For
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teins present in IANK cells21 and that the fluorescence intensity observed in permeabilized cells treated with anti-G protein is not due to allosteric binding of these antibodies.
MIP-la, RANTES, and MCP-1 induce the chemotaxis of intact IANK cells.'8 To more specifically identify the nature of G proteins, which may be part of the pathway transducing the chemotactic signal of CC chemokines, we introduced 1 : 100 dilution of affinity-purified anti-G protein antibodies into permeabilized cells. Figure 3 shows that SLO-penneabilized IANK cells were capable of migrating in response to MIP-la, RANTES, and MCP-1 in the microchemotaxis assay. However, permeabilization affected the migratory behavior of these cells, because there are lower numbers (between 50% and 60%) of cells migrating when compared with unpermeabilized cells. More importantly, we observed that anti-9, anti-Go, and, to a lesser extent, anti-G, inhibited the chemoattraction of IANK cells in response to all three CC chemokines examined. However, anti-Gi inhibited the chemoattraction of IANK cells in response to RANTES and MCP-1 but not in response to MIP-la.
To further examine the coupling of CC chemokine receptors to various subtypes of G proteins, we incubated IANK cell membranes with anti-G protein antibodies before assaying for ( Y -~~S )
GTP binding or the hydrolysis of ( y -32P) GTP. Anti-Gi inhibited MCP-1 -induced or RANTESinduced GTP binding but not MIP-la-induced GTP binding (Fig 4A) or GTPase activity (Fig 5A) . On the other hand, anti-G,, anti-Go, or anti-G, inhibited all three chemokineinduced GTP binding (Fig 4A) or GTPase activity (Fig 5A) in IANK cell membranes.
To confirm the results obtained using anti-G protein antibodies, we incubated these antibodies with their corresponding synthetic peptides before addition to IANK cell membranes. Using 200 ng/mL of the synthetic peptides, ai reversed the inhibitory effect of anti-G, for MCP-1 or RANTES activation of GTP binding (Fig 4B) or GTPase activity (Fig 5B) . Similarly, a,, as, and a, reversed the inhibitory effect of anti-Go, anti-G,, and anti-G,, respectively, for MIP-la, MCP-1, or RANTES-induced GTP binding ( Fig  4B) or GTP hydrolysis (Fig 5B) in IANK cell membranes. The addition of 200 ng/mL of each of the synthetic peptides to NRS or rabbit IgG did not affect CC chemokine enhancement of GTP binding (Fig 4B) or GTP hydrolysis (Fig 5B) in these membranes.
DISCUSSION
The antitumor effector IANK cells that have been used for the treatment of cancer are rigidz4 and are unable to extravasate into various tissues.2' We have recently reported that members of CC chemokines are capable of activating the CD56' NK cellsz6 and of inducing the chemotaxis of IANK cells." We also reported that MIP-la, MCP-1, and RANTES enhance GTP binding and GTPase activity in IANK cell membranes.I8
In this report, we explored the coupling of CC chemokine receptors to various subtypes of the heterotrimeric G protein in IANK cells. First, we showed that incorporating anti-G protein antibodies inside SLO-permeabilized cells is a feasible method to examine various biologic activities such as chemotaxis in these cells. Using this technique, we observed that anti-G,, anti-G,, and anti-G, inhibited MIP-la-, MCP-I-, or RANTES-induced IANK cell chemotaxis, whereas anti-Gi inhibited only MCP-1 and RANTES but not MIPla induction of IANK cell chemotaxis.
Similarly, incubating IANK cell membranes with anti-G protein antibodies before incubating with the CC chemokines showed that anti-Go, anti-Gs, and anti-G, inhibited MIP-la-, MCP-1 -, or RANTES-induced GTP binding and GTPase activity in IANK cell membranes, whereas anti-Gi inhibited only MCP-1-and RANTES-but not MIP-la-induced GTP binding and GTPase activity in these membranes. The specificity of the anti-G protein activity was determined by binding these antibodies with the immunogenic synthetic peptides before addition to IANK cell membranes.
These results suggest that receptors for MIP-la are differently coupled to G proteins than are receptors for RANTES and MCP-1. They support our earlier findings showing that pertussis toxin inhibits RANTES-and MCP-1-but not MIP-1 a-induced IANK cell chemotaxis, whereas cholera toxin inhibits the chemotaxis of IANK cells in response to MIPla, RANTES, and MCP-I." Hence, receptors for MIP-la are coupled to at least G,, Go, and G, but not to the pertussis toxin-sensitive Gi. In contrast, receptors for RANTES and MCP-1 are promiscuously coupled to all subtypes of G proteins examined.
The difference in the coupling of MIP-la receptors to those of MCP-1 and RANTES is surprising because, in other cell types MIP-la shares the same receptors with RANTES.2*'o." However, it is likely that the relationship of individual chemokine receptors with their ligands and G proteins is complex. It has been previously shown that signaling desensitization between RANTES and MIP-la on cells bearing the shared CC chemokine receptor is asymmetrical.Io Thus, it is possible that, in IANK cells, MIP-la may share the same receptor with RANTES, but the signal transduction pathway of these two CC chemokines might be different. Work is currently underway to resolve these important issues.
Our data may be important when considering the ability of IANK cells to treat cancer in preclinical and clinical studies. They suggest that the antitumor effector cells can be attracted toward the concentration sites of the inflammatory mediator CC chemokines and that G proteins are important for their migration. Therefore, G proteins could be targeted to stimulate the migration of these cells toward the desired areas in the body or to inhibit their distribution toward other areas where they could be detrimental to the host. Secondly, this is the first report that clearly identifies the nature of G proteins coupled to the inflammatory mediator CC chemokine receptors. The coupling of RANTES and MCP-1 receptors to multiple subtypes of G proteins is similar to the coupling of the adrenoreceptor a2, one of the few other Gprotein-linked receptors that appears to have the capacity for linkage to many different G protein subtypes."
